The Situation
A top global pharmaceutical company needed a trusted competitive strategy partner to support business development scouting, long-term portfolio strategy, and clinical development across four therapeutic areas: Immunology, Inflammation, Rheumatology, and Nephropathy. The organization required continuous visibility into assets in development, emerging competitors, and evolving clinical data, delivered in a way that could directly inform prioritization and investment decisions.
The Solution
Sedulo deployed a dedicated team of therapeutic-ready competitive research and strategy professionals to deliver integrated support across monitoring, landscaping, and conference intelligence.
Ongoing Competitive Monitoring
Sedulo implemented a proactive monitoring program featuring Daily News Flash Alerts, Monthly News Summaries, and in-depth tracking of business development targets. Each quarter, the team delivered investor relations call summaries for priority companies, ensuring comprehensive yet efficient coverage of market activity.
Indication-Specific Ad Hoc Landscapes
Sedulo produced flexible, indication-focused landscape reports leveraging deep secondary research to identify and analyze all potential BD-relevant assets (Pre-Clinical and beyond). Each landscape included clinical data comparisons and five-year approval projections to support evidence-based prioritization.
End-to-End Conference Coverage
Sedulo provided conference planners, abstract analyses, session and poster prioritization, daily email updates, and detailed post-conference reports summarizing key data readouts and competitive implications across priority therapeutic areas.
The Impact
The client gained a consistent, high-confidence view of competitive dynamics across four therapeutic areas, enabling faster and more informed BD scouting, clearer long-term strategic planning, and stronger alignment between strategy and clinical development teams. Sedulo’s integrated approach transformed disparate competitive signals into actionable intelligence that directly supported portfolio and investment decisions.